Silicon Laboratories Inc.
SLAB
$128.77
-$3.00-2.28%
NASDAQ
| 04/05/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.16% | -25.29% | -47.00% | -46.77% | -38.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.16% | -25.29% | -47.00% | -46.77% | -38.11% |
| Cost of Revenue | 7.42% | -15.38% | -36.88% | -37.80% | -29.36% |
| Gross Profit | -1.91% | -32.22% | -53.67% | -52.52% | -43.53% |
| SG&A Expenses | 13.18% | -1.05% | -10.79% | -26.93% | -29.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.64% | -7.01% | -18.73% | -23.43% | -20.08% |
| Operating Income | -34.59% | -585.15% | -387.51% | -284.59% | -197.73% |
| Income Before Tax | -20.22% | -482.60% | -350.00% | -262.40% | -189.94% |
| Income Tax Expenses | 19,833.85% | 355.71% | -9.22% | -32.71% | -100.56% |
| Earnings from Continuing Operations | -57.09% | -453.40% | -490.84% | -377.94% | -227.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.09% | -453.40% | -490.84% | -377.94% | -227.34% |
| EBIT | -34.59% | -585.15% | -387.51% | -284.59% | -197.73% |
| EBITDA | -75.40% | -534.16% | -229.22% | -181.69% | -132.57% |
| EPS Basic | -55.38% | -449.38% | -492.01% | -384.28% | -234.20% |
| Normalized Basic EPS | -18.88% | -480.22% | -350.30% | -266.22% | -194.99% |
| EPS Diluted | -54.32% | -424.32% | -506.41% | -395.13% | -239.75% |
| Normalized Diluted EPS | -17.69% | -435.54% | -358.73% | -271.80% | -198.71% |
| Average Basic Shares Outstanding | 1.69% | 1.22% | 0.22% | -1.93% | -5.31% |
| Average Diluted Shares Outstanding | 0.43% | -1.41% | -2.90% | -5.02% | -6.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |